Novo Nordisk’s $1.2 Billion Investment in Denmark Explained
JYOTI 🔹Novo Nordisk has announced a major investment of DKr8.5bn ($1.2bn) to establish a new production facility in Odense,…
Pharma News
Guide for Patients and Caregivers: Managing Spinal Cord Injuries
Spinal cord injuries (SCIs) can have profound effects on motor and sensory function, depending on the location and…
Cipla has launched India’s first inhalable insulin
RAJLAXMI 🔷Cipla has launched India’s first inhalable insulin, Afrezza, after receiving approval from the Central Drugs Standard Control Organisation…
Main Stock Types: Key Information You Need to Know
Main strock type: ♦️Artery to Artery embolism; 🔹Vulnerable plaque ruptures & causes clot formation 🔹Occludes the artery &…
Strategies for Pharma Exporters to Overcome Regulatory Barriers
Arpita Section 43B(h) of the Income Tax Act, introduced in April 2024, likely aims to streamline tax compliance and…
Host-tumor Interaction and Immune Evasion 🦠
♦️Host-tumor interactions are complex interactions between tumor cells and the host immune system that influence tumor progression, metastasis,…
Breakthrough in Lung Cancer: Imfinzi’s FDA Approval for Limited-Stage SCLC Patients
AstraZeneca’s (AZ) Imfinzi (durvalumab) has received approval from the US Food and Drug Administration (FDA) for treating adults…
Innovations in Media Fill Testing: What the Pharmaceutical Industry Needs to Know
The advancements in pharmaceutical manufacturing technologies, particularly in media fill testing, represent a significant leap forward in ensuring…
Global Orally Disintegrating Tablet (ODT) Market is expected to exceed more than US$ 26.50 Bn by 2025 at a CAGR of 11.5% in the given forecast period
Global Orally Disintegrating Tablet Market Overview: An Orally Disintegrating Tablet is a drug dosage form available for a…
INNOVATION VERTE : INSIDE LOOK AT PUNE’S LUPIN RESEARCH PARK R&D FACILITIES
Lupin Limited, a prominent global pharmaceutical company, has announced that its Research and Development facility at the Lupin…